Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Postoperative Hemorrhage D019106 7 associated lipids
Leukostasis D018921 1 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Pelvic Pain D017699 7 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Michibayashi T Platelet aggregation and vasoconstriction related to platelet cyclooxygenase and 12-lipoxygenase pathways. 2005 J. Atheroscler. Thromb. pmid:16020916
Mishra RK et al. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). 2005 Allergy pmid:16076309
Jin Y et al. Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor. 2005 Eur. J. Immunol. pmid:16078278
Meyer MC et al. Potential role for mast cell tryptase in recruitment of inflammatory cells to endothelium. 2005 Am. J. Physiol., Cell Physiol. pmid:16079184
Fernandes ES et al. Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression. 2005 Br. J. Pharmacol. pmid:16025141
Xie DS and Xie YT [Role of platelet activating factor in hepatorenal syndrome]. 2005 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:16045031
Marathe GK et al. Ultraviolet B radiation generates platelet-activating factor-like phospholipids underlying cutaneous damage. 2005 J. Biol. Chem. pmid:16115894
Chang GT et al. Purification and characterization of a new anticoagulant protein, PP27, from placenta. 2005 Thromb. Res. pmid:16122555
Ezoulin MJ et al. Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells. 2005 Neurosci. Lett. pmid:16095823
Choi IW et al. TNF-alpha induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A(2) activation. 2005 J. Allergy Clin. Immunol. pmid:16159621
Burgos RA et al. 14-deoxyandrographolide as a platelet activating factor antagonist in bovine neutrophils. 2005 Planta Med. pmid:16041644
Caplan MS et al. The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. 2005 Semin. Pediatr. Surg. pmid:16084401
Denizot Y et al. Platelet-activating factor and liver metastasis of colorectal cancer. 2005 Int. J. Cancer pmid:15455343
Shindou H et al. Priming effect of lipopolysaccharide on acetyl-coenzyme A:lyso-platelet-activating factor acetyltransferase is MyD88 and TRIF independent. 2005 J. Immunol. pmid:16002720
Black S et al. An intact phosphocholine binding site is necessary for transgenic rabbit C-reactive protein to protect mice against challenge with platelet-activating factor. 2005 J. Immunol. pmid:16002722
Koch E Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts. 2005 Phytomedicine pmid:15693702
Jantan I et al. Platelet-activating factor (PAF) receptor-binding antagonist activity of Malaysian medicinal plants. 2005 Phytomedicine pmid:15693713
El-Medany A et al. Attenuation of bleomycin-induced lung fibrosis in rats by mesna. 2005 Eur. J. Pharmacol. pmid:15713430
Ninio E Phospholipid mediators in the vessel wall: involvement in atherosclerosis. 2005 Curr Opin Clin Nutr Metab Care pmid:15716789
Evans L et al. A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from Phase I studies. 2005 J. Pharm. Pharmacol. pmid:15720781
Yoshida H et al. Platelet-activating factor enhances the expression of nerve growth factor in normal human astrocytes under hypoxia. 2005 Brain Res. Mol. Brain Res. pmid:15661369
Zhu L and He P Platelet-activating factor increases endothelial [Ca2+]i and NO production in individually perfused intact microvessels. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15665052
Cuschieri J et al. Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming. 2005 Shock pmid:15665723
Roudebush WE et al. The significance of platelet-activating factor and fertility in the male primate: a review. 2005 J. Med. Primatol. pmid:15667340
Ottino P et al. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts. 2005 Invest. Ophthalmol. Vis. Sci. pmid:15671273
Hidalgo MA et al. Andrographolide interferes with binding of nuclear factor-kappaB to DNA in HL-60-derived neutrophilic cells. 2005 Br. J. Pharmacol. pmid:15678086
Qu XW et al. Tetrahydrobiopterin prevents platelet-activating factor-induced intestinal hypoperfusion and necrosis: Role of neuronal nitric oxide synthase. 2005 Crit. Care Med. pmid:15891335
Gilli UO et al. Human polymorphonuclear neutrophils are recruited by porcine chemokines acting on CXC chemokine receptor 2, and platelet-activating factor. 2005 Transplantation pmid:15912099
Park EJ et al. Dietary ganglioside decreases cholesterol content, caveolin expression and inflammatory mediators in rat intestinal microdomains. 2005 Glycobiology pmid:15917432
Owen JS et al. Stress-induced platelet-activating factor synthesis in human neutrophils. 2005 Biochim. Biophys. Acta pmid:15863359
Göggel R and Uhlig S The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema. 2005 Eur. Respir. J. pmid:15863642
Martínez-Cócera C et al. Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study. 2005 J Investig Allergol Clin Immunol pmid:15864879
Yeh JH et al. 2-O-methyl PAF as a Ca2+ mobilizer in Madin Darby canine kidney cells. 2005 Life Sci. pmid:15878360
Cheng L et al. Hydrogen peroxide reduces lower esophageal sphincter tone in human esophagitis. 2005 Gastroenterology pmid:16285965
Medvedev IN and GromnatsiÄ­ NI [The influence of nebivolol on thrombocyte aggregation in patients with arterial hypertension with metabolic sydrome]. 2005 Klin Med (Mosk) pmid:15881638
Rastelli VM et al. Influence of insulin on the microvascular response to inflammatory mediators in neonatal streptozotocin diabetic rats. 2005 Inflamm. Res. pmid:15883740
Ko HM et al. Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis. 2005 FEBS Lett. pmid:15848174
Hardy P et al. New insights into the retinal circulation: inflammatory lipid mediators in ischemic retinopathy. 2005 Prostaglandins Leukot. Essent. Fatty Acids pmid:15850712
Chen LW et al. Different pathways leading to activation of extracellular signal-regulated kinase and p38 MAP kinase by formyl-methionyl-leucyl-phenylalanine or platelet activating factor in human neutrophils. 2005 J. Biomed. Sci. pmid:15917990
Goldring WP et al. Novel phomactin analogues as PAF receptor ligands. 2005 Bioorg. Med. Chem. Lett. pmid:15922596
Tombul T et al. Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction. 2005 J Clin Neurosci pmid:15925775
Boccellino M et al. Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility. 2005 Am. J. Pathol. pmid:15855650
Schram MT et al. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. 2005 Hypertension pmid:15851628
Denizot Y et al. Platelet-activating factor and human thyroid cancer. 2005 Eur. J. Endocrinol. pmid:15994743
Androulakis N et al. Molecular and mechanistic characterization of platelet-activating factor-like bioactivity produced upon LDL oxidation. 2005 J. Lipid Res. pmid:15995176
Grypioti AD et al. Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration. 2005 Arch. Toxicol. pmid:15995853
Chatterjee BE et al. Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. 2005 J. Leukoc. Biol. pmid:16000391
Guo NJ et al. [Activation of platelet-neutrophil mediated by platelet-activating factor]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:15972139
Souza DG and Teixeira MM The balance between the production of tumor necrosis factor-alpha and interleukin-10 determines tissue injury and lethality during intestinal ischemia and reperfusion. 2005 Mem. Inst. Oswaldo Cruz pmid:15962100
Castro Faria Neto HC et al. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase. 2005 Mem. Inst. Oswaldo Cruz pmid:15962103
Dong J et al. [Effect of platelet-activating factor on long-term potentiation in rat hippocampal slices]. 2005 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21171322
Estellés R et al. Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neutrophil recruitment in vivo. 2005 J. Leukoc. Biol. pmid:15944212
Zhao T and Bokoch GM Critical role of proline-rich tyrosine kinase 2 in reversion of the adhesion-mediated suppression of reactive oxygen species generation by human neutrophils. 2005 J. Immunol. pmid:15944312
McLarnon JG et al. Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients. 2005 J. Neurosci. Res. pmid:15948178
Ozger S et al. Effects of platelet-activating factor on nitrergic transmission in rabbit corpus cavernosum. 2005 Int. J. Urol. pmid:15985080
Asada Y [Inflammatory and immune responses in arterial thrombus formation]. 2005 Rinsho Ketsueki pmid:16447700
Kira J [Multiple sclerosis]. 2005 Rinsho Shinkeigaku pmid:16447761
Chen C and Bazan NG Lipid signaling: sleep, synaptic plasticity, and neuroprotection. 2005 Prostaglandins Other Lipid Mediat. pmid:16099392
Uhlig S et al. Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung. 2005 Pharmacol Rep pmid:16415501
Lang PA et al. Stimulation of erythrocyte ceramide formation by platelet-activating factor. 2005 J. Cell. Sci. pmid:15741229
Sheppard FR et al. Clinically relevant osmolar stress inhibits priming-induced PMN NADPH oxidase subunit translocation. 2005 J Trauma pmid:15824651
Leveau P et al. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant. 2005 Biochem. Pharmacol. pmid:15826603
Kumar S and Sharma A Platelet activating factor improves the in vitro penetration of zona free hamster eggs by buffalo (Bubalus bubalis) spermatozoa. 2005 Theriogenology pmid:15763101
Asai Y Formation of spherical micelles composed of the novel platelet activating factor receptor antagonist, E5880. 2005 Pharmazie pmid:15801673
Nacken W et al. S100A9 deficiency alters adenosine-5'-triphosphate induced calcium signalling but does not generally interfere with calcium and zinc homeostasis in murine neutrophils. 2005 Int. J. Biochem. Cell Biol. pmid:15778088
Minnear FL et al. Sphingosine 1-phosphate prevents platelet-activating factor-induced increase in hydraulic conductivity in rat mesenteric venules: pertussis toxin sensitive. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15778280
Perry SW et al. HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. 2005 J. Immunol. pmid:15778398
Ishiura Y et al. In vivo PAF-induced airway eosinophil accumulation reduces bronchial responsiveness to inhaled histamine. 2005 Prostaglandins Other Lipid Mediat. pmid:15789611
Gaudreault E et al. Involvement of leukotriene B4 receptor 1 signaling in platelet-activating factor-mediated neutrophil degranulation and chemotaxis. 2005 Prostaglandins Other Lipid Mediat. pmid:15789613
Calcerrada MC et al. Selective translocation of protein kinase c isozymes by PAF in rabbit platelets. 2005 Prostaglandins Other Lipid Mediat. pmid:15789614
Hudry-Clergeon H et al. Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PtdIns3'-kinase. 2005 FASEB J. pmid:15791001
Ersoy B et al. The role of platelet-activating factor in pathogenesis of type 1 diabetes. 2005 Diabetes Care pmid:15793212
Grigoriou O et al. Effect of sperm treatment with exogenous platelet-activating factor on the outcome of intrauterine insemination. 2005 Fertil. Steril. pmid:15749490
Cheng HH et al. Defect in regulation of Ca2+ movement in platelets from patients with systemic lupus erythematosus. 2005 Pharmacology pmid:15591819
Penna C et al. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. 2005 Am. J. Physiol. Heart Circ. Physiol. pmid:15637120
Meyer MC et al. Calcium-independent phospholipase A2 is regulated by a novel protein kinase C in human coronary artery endothelial cells. 2005 Am. J. Physiol., Cell Physiol. pmid:15643055
Granger J and Remick D Acute pancreatitis: models, markers, and mediators. 2005 Shock pmid:16374372
Wang CP et al. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats]. 2005 Zhonghua Yi Xue Za Zhi pmid:16409839
Karantonis HC et al. Synthesis and biological evaluation of novel steroid-modified ether phospholipids. 2005 Chem. Phys. Lipids pmid:16202400
Nagata M et al. Effect of the cysteinyl leukotriene antagonist pranlukast on transendothelial migration of eosinophils. 2005 Int. Arch. Allergy Immunol. pmid:15947477
Antonopoulou S et al. Bioactive polar lipids from Chroococcidiopsis sp. (Cyanobacteria). 2005 Comp. Biochem. Physiol. B, Biochem. Mol. Biol. pmid:16198133
Melo RC et al. Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. 2005 Traffic pmid:16138901
Ueda Y et al. Antianaphylactic and antipruritic effects of the flowers of Impatiens textori MIQ. 2005 Biol. Pharm. Bull. pmid:16141562
Chang GT et al. Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation. 2005 J Ethnopharmacol pmid:16125889
Iversen VV et al. Platelet activating factor (PAF) increases plasma protein extravasation and induces lowering of interstitial fluid pressure (P) in rat skin. 2005 Acta Physiol. Scand. pmid:16128692
Okumura N et al. Platelet-activating factor in human normal tears. 2005 Curr. Eye Res. pmid:16251126
Ko HM et al. Platelet-activating factor induces matrix metalloproteinase-9 expression through Ca(2+)- or PI3K-dependent signaling pathway in a human vascular endothelial cell line. 2005 FEBS Lett. pmid:16288746
Ward JR et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. 2005 Thromb. Haemost. pmid:16270639
Walz PH et al. Platelet function and association of bovine viral diarrhea virus with platelets of persistently infected cattle. 2005 Am. J. Vet. Res. pmid:16273905
Shargall Y et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part VI: treatment. 2005 J. Heart Lung Transplant. pmid:16210120
Fragopoulou E et al. Characterization of acetyl-CoA: lyso-PAF acetyltransferase of human mesangial cells. 2005 Mediators Inflamm. pmid:16258193
Besana A et al. Lipids and two-pore domain K+ channels in excitable cells. 2005 Prostaglandins Other Lipid Mediat. pmid:16099395
Shibamoto T et al. Involvement of platelet-activating factor and leukotrienes in anaphylactic segmental venoconstriction in ovalbumin sensitized guinea pig livers. 2005 Prostaglandins Other Lipid Mediat. pmid:16303618
Vieira-de-Abreu A et al. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx. 2005 Int. Immunopharmacol. pmid:16275631
Bellizzi MJ et al. Synaptic activity becomes excitotoxic in neurons exposed to elevated levels of platelet-activating factor. 2005 J. Clin. Invest. pmid:16276420
Yu P et al. Mitogen-activated protein kinases regulate platelet-activating factor-induced hyperpermeability. 2005 Microcirculation pmid:16284005
Buke AC et al. Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection. 2004 Sep-Oct Med Princ Pract pmid:15316260
Barbanoj MJ et al. Central and peripheral evaluation of rupatadine, a new antihistamine/platelet-activating factor antagonist, at different doses in healthy volunteers. 2004 Neuropsychobiology pmid:15539863
Besana A et al. Activation of protein kinase C epsilon inhibits the two-pore domain K+ channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes. 2004 J. Biol. Chem. pmid:15184378
Ma YQ et al. P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. 2004 Blood pmid:15217824